These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5141742)

  • 1. Rifampin in the treatment of drug-resistant TB.
    Vall-Spinosa A; Lester W; Moulding T; Davidson PT; McClatchy JK
    Md State Med J; 1971 Jun; 20(6):79-80. PubMed ID: 5141742
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary clinical observations on the use of Rifampicin in chronic cavitary pulmonary tuberculosis previously treated with and resistant to other drugs].
    Mauro G
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):461-6. PubMed ID: 5309059
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study on rifomycin in resumption of treatment of pulmonary tuberculosis cases with polyresistant bacilli].
    Prignot J; Gyselen A; Cosemans J; De Brabandere R; Verbist L; Simon-Pouthier F
    Acta Tuberc Pneumol Belg; 1969; 60(3):487-95. PubMed ID: 4906102
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new antitubercular agent: rifampicin].
    Favez G
    Schweiz Rundsch Med Prax; 1970 Feb; 59(8):296-7. PubMed ID: 4996719
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of treatment with rifampicin in 39 patients hospitalized in our service during 1970-1971-1972].
    Maalej M; Chabbou A; Zbiba M; El Gharbi B; Halfon S; El Gharbi T; Cheniti M; El Mekki L; Djen Ayah F; Chebbi ML; Jeguirim M; Ben Salah M
    Tunis Med; 1974; 52(6):313-6. PubMed ID: 4619937
    [No Abstract]   [Full Text] [Related]  

  • 8. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 9. [A-cohort study on the standard short-course chemotherapy program for drug resistant tuberculosis in the rural counties in Eastern China].
    Hu Y; Jiang WL; Wang WB; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):540-4. PubMed ID: 19040032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations].
    Rabukhin AE; Alekseeva VM; Ivanova ES; Kubyshkina VF; Kliuchareva EA
    Probl Tuberk; 1970; 48(8):18-22. PubMed ID: 5496733
    [No Abstract]   [Full Text] [Related]  

  • 11. New TB drug approved.
    AIDS Patient Care; 1995 Feb; 9(1):42. PubMed ID: 11361363
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 13. Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002.
    LoBue PA; Moser KS
    Int J Tuberc Lung Dis; 2005 May; 9(5):501-6. PubMed ID: 15875920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
    Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of tuberculosis: TB or not TB?
    Hopkins SJ
    Nurs Mirror; 1981 Jul; 153(5):32-3. PubMed ID: 6911684
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
    Stout JE
    Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the epidemiology and determinants of drug-resistant tuberculosis in northern rural area of Jiangsu province].
    Yang BF; Xu B; Jiang WL; Zhou PY; Jiang QW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):582-5. PubMed ID: 15308037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.